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Structural reinforcement of cell-laden hydrogels
with microfabricated three dimensional scaﬀolds†
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Hydrogels commonly used in tissue engineering are mechanically soft and thus often display structural
weakness. Herein, we introduce a strategy for enhancing the structural integrity and fracture toughness of
cell-laden hydrogels by incorporating a three-dimensional (3D) microfabricated scaﬀold as a structural
element. Digital micromirror device projection printing (DMD-PP) system, a rapid prototyping technology
which employs a layer-by-layer stereolithographic approach, was utilized to eﬃciently fabricate 3D
scaﬀolds made from photocrosslinkable poly(ethylene glycol) diacrylate (PEGDA). The scaﬀold was in-
corporated into a photocrosslinkable gelatin hydrogel by placing it in a pre-gel solution, and inducing
in situ hydrogel formation. The resulting scaﬀold-reinforced hydrogels demonstrated a signiﬁcant
increase in ultimate stress and provided structural support for mechanically weak hydrogels. In addition,
the scaﬀold did not aﬀect the rigidity of hydrogels, as it was not involved in the crosslinking reaction to
form the hydrogel. Therefore, the presented approach could avoid inadvertent and undesired changes in
the hydrogel rigidity which is a known regulator of cellular activities. Furthermore, the biocompatibility of
scaﬀold-reinforced hydrogels was conﬁrmed by evaluating the viability and proliferation of encapsulated
ﬁbroblasts. Overall, the strategy of incorporating 3D scaﬀolds into hydrogels as structural reinforcements
presented in this study will be highly useful for enhancing the mechanical toughness of hydrogels for
various tissue engineering applications.
1. Introduction
Hydrogels are widely used as scaﬀold materials for tissue
engineering applications, because their structure, a crosslinked
network of polymers with high fluid content and elasticity,
closely mimics native extracellular matrices (ECM) and therefore
provides a suitable microenvironment for cells and tissues.1–4
Various strategies have been employed to control the biochemi-
cal and mechanical properties of the hydrogels. For example,
ECM proteins (e.g. collagen, laminin and fibronectin)5–7 or their
functional peptide sequences (e.g. RGD peptide)8–10 are chemi-
cally incorporated into hydrogels to induce cell adhesion to the
hydrogel surface. The rigidity of hydrogels is often modulated
by controlling the crosslinking density.11,12
In order to emulate the natural biomechanical environment
of the cells, the hydrogel rigidity is often controlled to match
the inherent softness of native ECM.13–15 However, due to the
structural weakness of hydrogels, they are easily broken and
often display a high degree of swelling. As a result, handling
hydrogels becomes challenging, and their original structure and
dimensions often do not remain intact over time. There are
various reinforcement strategies to improve the toughness of the
hydrogels. For example, a secondary polymeric network is intro-
duced to strengthen the hydrogels (e.g. formation of interpene-
trating networks).16,17 In addition, nanostructures are
incorporated into the polymeric network to create composite
hydrogels (e.g. clay, minerals, polymeric and metal nano-
spheres).18,19 However, these approaches often result in changes
in rigidity and diﬀusion properties of hydrogels, which influence
the cellular phenotypes.20,21 Similarly, it has been shown that
nanostructures could elicit non-specific responses from cells.22
Therefore, it is desirable to employ a strategy that only enhances
the structural integrity and fracture resistance of hydrogels
without inadvertently influencing their cell responsiveness.
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Here, we present an approach to enhance the structural
integrity and toughness of hydrogels by introducing a 3D poly-
meric scaﬀold designed to act as a structural framework to
reinforce the hydrogels. This approach was inspired by the
endoskeletal system of vertebrate species, which has evolved
not only to provide structural support and protection for tissue
structures, but also to guide their overall shape.23 Therefore,
we hypothesized that the presence of a solid scaﬀold would
support the structural integrity and increase the fracture
strength of soft cell-laden hydrogels without aﬀecting their
rigidity. The scaﬀold made of poly(ethylene glycol)diacrylate
(PEGDA) was developed by digital micromirror device projec-
tion printing (DMD-PP), a rapid prototyping stereolithography
technique which allows for a highly eﬃcient fabrication of
three dimensional (3D) structures in micro-scale dimensions.24–27
The concentration of PEGDA was varied to control the flexi-
bility of the scaﬀolds. Then, the scaﬀold was immersed in a
pre-gel solution containing methacrylated gelatin (GelMA) and
a photoinitiator, followed by UV irradiation to fabricate the
scaﬀold-reinforced hydrogels. The mechanical properties of the
scaﬀold-reinforced GelMA hydrogels were evaluated by measur-
ing elastic moduli and ultimate stress, and were compared
with those of pure GelMA hydrogels to evaluate the reinforcing
eﬀect of the PEGDA scaﬀold. Furthermore, fibroblasts were
encapsulated within the scaﬀold-reinforced hydrogels and
their viability and proliferation were evaluated to assess the
eﬀect of scaﬀolds on the cellular viability and proliferation.
2. Experimental section
2.1. Synthesis of methacrylated gelatin (GelMA)
Gelatin (10 g, Sigma Aldrich) and 4-dimethylaminopyridine
(0.5 g, Sigma Aldrich) were dissolved in dimethyl sulfoxide
(90 mL, Fisher) at 50 °C. Then, glycidyl methacrylate (4 mL,
Sigma Aldrich) was slowly added to the solution, and the
mixture was continuously stirred at 50 °C for 48 hours under
dry N2. The mixture was dialyzed against deionized (DI) water,
and lyophilized to obtain the product. The chemical conju-
gation of methacrylate to gelatin was confirmed by 1H-NMR
(ESI Fig. 1†).
2.2. Fabrication of PEGDA scaﬀolds with digital micromirror
device projection printing (DMD-PP)
The schematic diagram of the DMD-PP system is shown in
Fig. 1a. The system consists of five major components: a com-
puter-based control system, a DMD chip (Texas Instruments), a
UV light source (Green Spot, UV Source, Inc.), a projection lens
assembly, and a sample stage.24,28 UV light was guided
through a liquid-filled fiber optic cable (6.35 mm), which con-
verged via two bi-convex lenses (18 mm in diameter, 40 mm in
focal length, 5 mm in spacing between lenses, Edmund
Optics) to the DMD chip. The projection lens assembly, which
focuses the UV light to the sample stage, consisted of two
equal plano-convex lenses (25 mm in diameter, 25 mm in focal
length, Edmund Optics). The aperture was placed between the
two lenses. All lenses used in this experiment were made from
UV grade fused silica (Edmund Optics). The intensity of UV
light on the sample stage was 2 mW cm−2.
The DMD chip consists of an array of 442 000 (1920 × 1080)
reflective aluminum micromirrors, which can be tilted to
either −10° or +10° angles with respect to the surface, which
act as an “on” or “oﬀ” switch; only the light reflected oﬀ the
+10° micromirror goes into the projection lens and to the
sample stage, and is therefore used to fabricate the scaﬀold
(“on”), and the light reflected oﬀ the −10° micromirror is
collected by a light absorber (“oﬀ”) (ESI Fig. 2†).
The pattern of each layer of the scaﬀold was programmed
into the DMD chip. The UV light reflected oﬀ the defined
pattern of the DMD chip went through the projection lens
assembly and onto the sample stage which was loaded with a
pre-gel solution consisting of varying concentrations of PEGDA
(20–100 wt%, MW 700) and Irgacure®2959 (0.5 wt%). The
sample stage was adjusted vertically on a micrometer scale to
determine the height of each layer. Only the UV-irradiated area
was polymerized under one exposure, while the unexposed
area remained in the liquid phase. After fabricating one layer,
the stage was lowered and a fresh pre-gel solution was placed,
Fig. 1 (a) Schematics of the digital mirror device projection printing
(DMD-PP) system used to fabricate three dimensional (3D) PEGDA
scaﬀolds. (b) The 3D scaﬀold was made via a layer-by-layer approach to
assemble multiple scaﬀold layers. Each layer consisted of evenly spaced
parallel bars. The photographs show top and side views of the scaﬀold
(scale bar: 1 mm).
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followed by UV exposure to fabricate the next layer on top of
the previous one. These steps were repeated sequentially to
develop the desired 3D scaﬀold.
2.3. Fabrication of scaﬀold-reinforced hydrogels
The scaﬀold was first placed in a custom-made mold made
from PDMS elastomer (Sylgard® 184, Dow Corning). The pre-
gel solution containing GelMA (5–10 wt%) and Irgacure® 2959
(0.1 wt%) was placed in the mold. The solution readily pene-
trated into the scaﬀold, and covered the entire mold. Then, UV
irradiation was applied to induce polymerization to form
hydrogels (2 minutes, output power of 4.8 mW cm−2, Omni-
Cure® S2000) (ESI Fig. 3†). The resulting scaﬀold-reinforced
hydrogel was taken out of the mold, and placed in phosphate
buﬀered saline (PBS, pH 7.4) for further characterization.
The overall dimensions of the scaﬀold-reinforced hydrogels
were 8 mm × 8 mm × 2.5 mm. The GelMA hydrogel without
the scaﬀold was also fabricated as a control.
Scanning electron microscopy (SEM) was used to character-
ize the detailed morphology of the scaﬀold-reinforced hydro-
gels. A sample was frozen in liquid nitrogen, and fractured to
expose the cross-section. Then the sample was dried via
lyophilization, sputter-coated with gold (2 nm thickness, IBS/
TM200S, VCR Group, Inc.), and visualized under a SEM
(Quanta 200 FEG, FEI™) under high vacuum.
2.4. Evaluation of mechanical properties
The mechanical properties of the scaﬀolds, hydrogels, and
scaﬀold-reinforced hydrogels were evaluated by measuring
stress–strain curves via uniaxial compression at the rate of
1 mm min−1 until they were completely fractured, using a
mechanical testing system (Model 5943, Instron®).12,29 The
elastic modulus of each sample was calculated from the slope
of a stress–strain curve at the first 10% strain where the curve
was linear. Ultimate stress was determined as the maximum
stress before the scaﬀold-reinforced hydrogel became fractured.
Cyclic uniaxial compression tests were performed on the
PEGDA scaﬀolds to further characterize their mechanical
strengths. Briefly, each scaﬀold was compressed (‘loading’)
and decompressed (‘unloading’) at the rate of 1 mm min−1 for
5 times continuously, and the stress–strain curve for both
loading and unloading was recorded (Model 5943, Instron®).
2.5. Cell studies
NIH-3T3 fibroblasts were suspended in the pre-gel solution
(cell density: 2 × 106 cells per mL). Then, the scaﬀold-
reinforced hydrogel was prepared as described above to encap-
sulate the cells. The constructs were incubated in the cell-
culture media (Dulbecco’s modified Eagle medium sup-
plemented with 10% fetal bovine serum and 1% penicillin/
streptomycin, all purchased from Invitrogen) at 37 °C with 5%
CO2 throughout the culture period.
To determine the viability of encapsulated cells, each
sample was taken at a designated time point and the cells
were fluorescently labeled with calcein-AM and ethidium
homodimer-1 to identify live (green fluorescence) and dead
(red fluorescence) cells, respectively (LIVE/DEAD® Viability/
Cytotoxicity Assay kit, Invitrogen), and then visualized using a
fluorescence microscope (Eclipse Ti, Nikon). The viability was
reported as the percentage of live cells from the total number
of cells. To evaluate the actin cytoskeleton organization of cells
within the hydrogel constructs, the cells were stained with
Alexa Fluor®488-phalloidin (Invitrogen) and visualized using
the fluorescence microscope.
3. Results and discussion
3.1. Microfabrication of PEGDA scaﬀolds
DMD-PP was used to fabricate 3D scaﬀolds which would be
used as the structural framework for hydrogels (Fig. 1a). This
rapid prototyping stereolithographic method utilizes a DMD
chip which allows for the fabrication of micropatterned
scaﬀolds by controlling the photocrosslinkable area with
switchable micromirrors (ESI Fig. 2†). Each UV exposure
reflected from the DMD chip to a gel-forming solution results
in a single layer of scaﬀold. This photocrosslinking step was
repeated on top of the previous layer to ultimately fabricate a
multi-layered 3D scaﬀold. By controlling the DMD chip to
adjust the photocrosslinked area, the architecture of the
scaﬀold could be easily controlled on a micrometer scale.
Herein, the scaﬀold made of photocrosslinked PEGDA con-
sisted of four layers, each consisting of evenly spaced (1 mm)
parallel bars having 200 μm width, 400 μm height, and 7 mm
length (Fig. 1b). Each layer was aligned perpendicular to the
previous one, so the inner space of the scaﬀold was connected
throughout the structure; this ensures that the pre-gel solution
can penetrate into the entire scaﬀold.
The concentration of PEGDA was varied from 20 wt% to
100 wt%, and then the mechanical properties of the resulting
scaﬀolds were evaluated by uniaxial compression in the
z-direction (Fig. 2a). The stress–strain curves obtained from
Fig. 2 (a) Mechanical properties of PEGDA scaﬀolds were obtained via
uniaxial compression. (b) A stress–strain curve of the PEGDA scaﬀold
(100 wt%). Multiple break points within the curve (identiﬁed with arrows)
are due to the gradual and partial fracture of the scaﬀold during the
compression. (b) Elastic moduli (E) of the PEGDA scaﬀolds made with
varying concentrations of PEGDA (*p < 0.05).
Biomaterials Science Paper


































the uniaxial compression showed several breaks with increas-
ing strain, due to gradual and partial breakage of the scaﬀolds
(Fig. 2b, ESI Fig. 4†). Elastic modulus, which was determined
from the slope of the initial linear region of the stress–strain
curve, could be controlled in a wide range from 15.5 kPa to
1.6 MPa, demonstrating that the rigidity of the scaﬀold could
be conveniently controlled by concentration of gel-forming
polymers (Fig. 2c). Similar stress–strain profiles were obtained
when the scaﬀolds were compressed in the y-direction (ESI
Fig. 5†). However, the ultimate stress values for more flexible
50 wt% and 20 wt% PEGDA scaﬀolds were higher than those
obtained in the z-direction, likely due to the enhanced ability
of the scaﬀold to bend along the longer axis (y-direction) than
the shorter axis (z-direction).
The mechanical strengths of the PEGDA scaﬀolds were
further characterized by cyclic uniaxial compression (Fig. 3).
The scaﬀolds were subjected to continuous loading and
unloading for 5 cycles, and their stress–strain curves were
obtained. There were no significant losses in stress values
when they were repeatedly compressed below the initial break
strain (<15%, Fig. 3a–c (left)). Even when they were compressed
beyond their initial break strain, there were only small
decreases in stress values (Fig. 3a–c (right)). These results
further demonstrated their mechanical strengths and their
eﬃcacy as structural elements to reinforce soft hydrogels.
3.2. Fabrication of scaﬀold-reinforced hydrogels
The PEGDA scaﬀold developed via DMD-PP, as described
above, was used as a structural framework to improve the
mechanical strength of hydrogels. For this study, GelMA
was used as a model hydrogel system which has been success-
fully used in several applications.30–34 First, the PEGDA
scaﬀold was placed in a mold, followed by the addition of a
pre-gel solution (Fig. 4a, ESI Fig. 3†). The solution quickly
spread throughout the scaﬀold, indicating that the spacing
within the scaﬀold was wide enough that the pre-gel solution
overcame its surface tension and readily penetrated into the
scaﬀold (ESI Fig. 6†).35,36 It was also likely facilitated by the
hydrophilic nature of PEGDA; the solution could spread more
readily through a highly wettable surface of PEGDA scaﬀolds.
The GelMA pre-gel solution placed in the scaﬀold was
then irradiated with UV to fabricate the scaﬀold-reinforced
hydrogel.
To demonstrate whether the scaﬀold could provide struc-
tural support for weak hydrogels, 5 wt% GelMA was used to
fabricate the hydrogels, which displayed weak structural inte-
grity and strength (Fig. 4b (left)). However, when the scaﬀold
was introduced into these GelMA hydrogels, the original struc-
ture was well maintained (Fig. 4b (right)).
SEM was used to characterize the detailed morphology of
scaﬀold-reinforced hydrogels. The cross-sectional SEM image
showed that the GelMA hydrogel was present throughout the
inner space of the scaﬀold, and there was no significant
gap between the scaﬀold and GelMA hydrogels (Fig. 4c).
This observation further confirmed that the pre-gel solution
penetrated well into the scaﬀold, and the scaﬀold did not
hinder the photocrosslinking reaction to form the GelMA
hydrogel.
Fig. 3 Stress–strain curves of (a) 100 wt%, (b) 50 wt% and (c) 20 wt%
PEGDA scaﬀolds were obtained via cyclic compression (5 cycles). Cyclic
tests were done either below (left graphs) or past (right graphs) the
initial break strain.
Fig. 4 (a) Schematics of the process to fabricate scaﬀold-reinforced
hydrogels. The microfabricated PEGDA scaﬀold was placed in a mold,
and the pre-gel solution containing GelMA and a photoinitiator was
added. Subsequent UV-initiated polymerization led to scaﬀold-
reinforced hydrogel formation. (b) GelMA hydrogels at 5 wt% had a weak
structural integrity whereas the structural integrity of the scaﬀold-
reinforced GelMA hydrogel at the same concentration was well main-
tained. (c) SEM image of a cross-section of scaﬀold-reinforced GelMA
hydrogels (scale bar: 200 μm).
Paper Biomaterials Science


































3.3. Mechanical properties of scaﬀold-reinforced hydrogels
The rigidity and toughness of the scaﬀold-reinforced GelMA
hydrogels were evaluated by measuring the elastic modulus,
ultimate strain, and ultimate stress from uniaxial compression
to investigate the eﬀect of the scaﬀolds on the mechanical pro-
perties of the hydrogels. First, the rigidity of the PEGDA
scaﬀolds was kept constant by using those made from 100 wt%
PEGDA, and varying concentrations of GelMA, from 5 wt%
to 10 wt%, were used to fabricate the scaﬀold-reinforced
GelMA hydrogels (Fig. 5a, ESI Fig. 7†). As expected, the ulti-
mate stress values of the GelMA hydrogels were significantly
increased by the incorporation of the scaﬀolds, since the
scaﬀolds acted as structural supports to protect the hydrogels
from fracture (Fig. 5b). Interestingly, there was a greater
increase in ultimate strain with increasing concentration of
GelMA hydrogels (Fig. 5c). It is suggested that a greater mecha-
nical strength of GelMA hydrogels at higher concentrations
likely contributed to the mechanical strength of the overall
scaﬀold-reinforced hydrogel. Elastic moduli of the GelMA hydro-
gels, on the other hand, were not aﬀected by the presence of
scaﬀolds regardless of GelMA concentrations, because the
scaﬀolds were not involved in the crosslinking reaction of the
GelMA hydrogel (Fig. 5d). These findings highlight the advan-
tage of using a microfabricated scaﬀold as a structural frame-
work, as it can significantly improve the mechanical strength of
the hydrogels without altering their rigidity which is a known
regulator of various cellular functions.14,15 Conventional strat-
egies to improve the mechanical strength of hydrogels, such as
controlling the crosslinking density and creating composite
systems, also significantly aﬀect the rigidity of hydrogels.
We further explored the eﬀect of the PEGDA scaﬀold on the
mechanical properties of GelMA hydrogels by varying the rigid-
ity of the PEGDA scaﬀolds (Fig. 6a). The concentration of
GelMA hydrogels was 10 wt%, and scaﬀolds made from
varying concentrations of PEGDA (20, 50, and 100 wt%), as
shown in Fig. 2, were used to reinforce the hydrogels. As
expected, elastic moduli of the GelMA hydrogels were not
aﬀected by the rigidity of the scaﬀolds. On the other hand,
their ultimate stress increased with the rigidity of the scaﬀolds
(Fig. 6b), which further proves that the rigidity of the scaﬀold
directly aﬀects the mechanical strength of the overall scaﬀold–
hydrogel constructs.
3.4. Cell encapsulation in scaﬀold-reinforced hydrogels
To evaluate the eﬀect of scaﬀold reinforcement on the bio-
compatibility of cell-laden hydrogels, NIH-3T3 fibroblasts were
encapsulated within GelMA hydrogels and GelMA hydrogels
reinforced with PEGDA scaﬀolds. The concentration of GelMA
hydrogels was 8 wt%, and the scaﬀold made from 100 wt%
PEGDA was used to reinforce the GelMA hydrogels. The viabi-
lity of fibroblasts in GelMA, regardless of the presence of the
scaﬀold, was well maintained (>80%) throughout the culture
period (Fig. 7a and b). The cells within the hydrogels began to
spread after 3 days of culture and proliferated within the
hydrogel over time. After 3 weeks of culture, the cells prolifer-
ated extensively and covered the entire hydrogel area, resulting
in a translucent tissue construct (Fig. 7c, ESI Fig. 8†). This
result demonstrated that introducing the scaﬀold to structu-
rally reinforce the hydrogels did not hinder the activities of
encapsulated cells.
The use of scaﬀolds as structural reinforcement would be
especially beneficial to supporting weak cell-laden hydrogels.
Hydrogels having low crosslinking density are not only struc-
turally weak, but also usually display high swelling properties.
Therefore, those hydrogels often result in premature structural
disintegration during cell culture, which is facilitated by the
cell-induced degradation. In order to demonstrate the scaﬀold
of supporting weak hydrogels, we fabricated the scaﬀold-
reinforced hydrogels encapsulated with fibroblasts using 5 wt%
GelMA, which has low elastic modulus (0.3 kPa) and ultimate
stress (20 kPa), as shown in Fig. 5. As expected, the pure
GelMA hydrogel began to swell extensively, and the overall
structure disintegrated during 7 days of culture (Fig. 8a). On
the other hand, the swelling and structural disintegration of
Fig. 5 (a) Stress–strain curves of GelMA (10 wt%) and scaﬀold-
reinforced GelMA hydrogels (scaﬀold-GelMA hydrogels) obtained from
uniaxial compression. The microfabricated scaﬀold was made from
100 wt% PEGDA. (b) Ultimate stress, (c) ultimate strain and (d) elastic
moduli (E) values of GelMA hydrogels and scaﬀold-GelMA hydrogels.
The concentration of GelMA was varied from 5 wt% to 10 wt%
(*p < 0.05).
Fig. 6 (a) Stress–strain curves of GelMA hydrogels (10 wt%) reinforced
with PEGDA scaﬀolds with varying rigidity. The scaﬀolds were made by
varying the concentration of PEGDA (20, 50 and 100 wt%). (b) Ultimate
stress values of scaﬀold-GelMA hydrogels with varying the scaﬀold
rigidity (*p < 0.05).
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the GelMA hydrogel was prevented by the presence of the
scaﬀold during the same time period (Fig. 8b). This result
demonstrated that the PEGDA scaﬀold could successfully
prolong the shape maintenance of weak cell-laden hydrogels.
3.5. Eﬀect of scaﬀold rigidity on encapsulated cells
We further explored the eﬀect of scaﬀold rigidity on the cells
encapsulated within GelMA hydrogels. PEGDA scaﬀolds with
varying rigidity were developed by controlling the concen-
tration of PEGDA used, from 20 to 100 wt%, as shown in
Fig. 2c. The viability of fibroblasts encapsulated within GelMA
hydrogels (8 wt%) measured over time was not aﬀected by the
rigidity of the scaﬀold; high viability (>80%) was demonstrated
under all conditions (ESI Fig. 9†). Interestingly, the cell mor-
phology and proliferation were significantly influenced by the
scaﬀold rigidity; the cells were able to spread and proliferate
more quickly within the GelMA hydrogel reinforced with softer
scaﬀolds (Fig. 9). It is well known that fibroblasts are able to
sense mechanical signals imparted by their 3D ECM, which in
turn allows the cells to exert their force on their surrounding
ECM, leading to matrix remodeling, spreading, migration, and
proliferation.37,38 During these events, the overall ECM struc-
ture undergoes contraction by the cellular activities. Therefore,
it is suggested that the presence of highly rigid scaﬀolds (i.e.
100 wt% PEGDA) may render the hydrogel too stringent,
restricting the cells’ ability to exert their force and thus sub-
sequent cellular activities, whereas the softer scaﬀolds allow
the hydrogels to be more contractile. It is also possible that the
diﬀerence in internal tension within the hydrogels, created by
the diﬀerence in scaﬀold rigidity, may have influenced diﬀer-
entially the encapsulated cells. Regardless of the scaﬀold rigid-
ity, the cells within the GelMA hydrogels all demonstrated a
high proliferative capacity and resulted in translucent tissue
constructs.
4. Conclusion
Taken together, we have demonstrated a practical approach to
significantly enhance the toughness of cell-laden hydrogels for
tissue engineering applications, by introducing a 3D micro-
fabricated scaﬀold designed to act as a structural support. A
rapid prototyping technology based on a digital micromirror
device projection printing system allowed for eﬃcient fabrica-
Fig. 7 (a) Fluorescent microscopic images of GelMA and scaﬀold-
GelMA hydrogels, encapsulated with ﬁbroblasts at days 1, 5 and 10. The
cells were stained with calcein-AM (green, live cells) and ethidium
homodimer-1 (red, dead cells) (scale bar: 100 μm). (b) The viability of
encapsulated ﬁbroblasts in GelMA and scaﬀold-GelMA hydrogels. (c)
Fluorescent microscopic image of ﬁbroblasts within the scaﬀold-GelMA
hydrogel after 21 days of culture. The actin structure of cells was visual-
ized by labeling with Alexa®488-phalloidin. Dotted lines represent the
position of the scaﬀold.
Fig. 8 Macroscopic views of (a) GelMA hydrogels and (b) scaﬀold-
GelMA hydrogels (5 wt% GelMA) encapsulated with ﬁbroblasts, taken at
days 1, 4 and 7 of culture. The GelMA hydrogel without the scaﬀold dis-
integrated over time (a), whereas the GelMA hydrogel reinforced with
the scaﬀold was well maintained during the same period (b).
Fig. 9 Fluorescent images of ﬁbroblasts encapsulated in GelMA hydro-
gels (8 wt%) supported with PEGDA scaﬀolds of varying rigidity (100, 50,
and 20 wt% PEGDA), taken at day 7 of culture (scale: 100 μm). The cells
were stained with Alexa®488-phalloidin to visualize their actin organiz-
ation. The area right of the dotted line represents the position of the
scaﬀold.
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tion of 3D scaﬀolds in microscale dimensions. The scaﬀold-
reinforced hydrogels demonstrated significantly enhanced
structural integrity and fracture toughness of the hydrogel
without inadvertently aﬀecting the rigidity of the hydrogel, a
known regulator of cell behavior. In addition, the biocompat-
ibility of scaﬀold-reinforced hydrogels was confirmed by evalu-
ating the viability and proliferation of encapsulated cells.
Therefore, we expect that the strategy of using 3D scaﬀolds for
hydrogel reinforcement will be highly useful for significantly
enhancing the mechanical strength of cell-laden hydrogels for
various tissue engineering applications.
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